Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
AI
Business
Football
Sport
Entertainment
Tech
Science

Gilead Sciences
Biotech
Topics

Advertisement

Advertisement

Gilead Sciences

Share

Top Latest Popular

Dr. Reddy's generic HIV prevention shot wins tentative FDA approval at $40 a year in 120 countries Medical Daily 4d

Medical Daily 4d

Gilead seeks wider use for Livdelzi on Phase III liver disease success Clinical Trials Arena 2d

Clinical Trials Arena 2d

Livdelzi Pharma

Gilead Sciences has raised its dividend for 11 straight years. Here's why the streak looks safe. The Motley Fool 3d

The Motley Fool 3d

Advertisement

Advertisement

Texas continues to target Pharma patient support programs under the Texas Anti-Kickback Statute JD Supra 1d

JD Supra 1d

Who supplied US firm's remdesivir for Nipah treatment in Kerala? Kmscl to probe Malayala Manorama 01:19 Sat, 31 Oct

Malayala Manorama 01:19 Sat, 31 Oct

US/India Pharma

Study: Legal departments 'flooded' with AI correspondence RTE 06:03 Tue, 27 Oct

RTE 06:03 Tue, 27 Oct

Rep. of Ireland Human Resources

Advertisement

Advertisement

Latest

Friday

Texas Continues to Target Pharma Patient Support Programs Under the Texas Anti-Kickback Statute JD Supra 21:29 Fri, 06 Nov

New Data Show Twice-Yearly Lenacapavir Achieved Nearly Twice the One-Year Persistence of Daily Oral F/Tdf in HIV Prevention Business Wire (Press Release) 17:19 Fri, 06 Nov

Gilead seeks wider use for Livdelzi on Phase III liver disease success Clinical Trials Arena 16:05 Fri, 06 Nov

Thursday

Gilead's Livdelzi Achieves 75% ALP Normalization In Phase 3 ideal Study; Stock Down RTT News 18:37 Thu, 05 Nov

AASLD 2026: Gilead Eyes Wider Livdelzi Use As Phase III Data Bolster PBC Expansion Plans Scrip Pharma Intelligence 15:54 Thu, 05 Nov

Gilead Sciences Has Raised Its Dividend for 11 Straight Years. Here's Why the Streak Looks Safe. The Motley Fool 11:00 Thu, 05 Nov

Wednesday

Stocks Surged Across the Board Today, and Biotech Brought Its Own Earnings Story PR Newswire (Press Release) 21:09 Wed, 04 Nov

FDA approval of generic lenacapavir will not guarantee access Doctors Without Borders (Press Release) 15:49 Wed, 04 Nov

Gilead and Kite Advance Leadership With New Data Across Pipeline and Portfolio at ash 2026 Business Wire (Press Release) 14:24 Wed, 04 Nov

Dr. Reddy's Generic HIV Prevention Shot Wins Tentative FDA Approval at $40 a Year in 120 Countries Medical Daily 01:39 Wed, 04 Nov

Advertisement

Advertisement

Advertisement

My Local News

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Industry Sectors Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna